| Particulars |
|
|
|
| Company Name
| Sun Pharmaceutical Industries Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
239.93 |
B.V. (₹) |
93.20 |
| Sales(₹ Cr.) |
20,609.02 |
NP (₹ Cr.) |
3,001.18 |
| NP Var% |
-30.00 |
Div% |
1,600.00 |
| CPS(₹) |
18.00 |
EPS (₹) |
12.50 |
| Traded Value(₹ Lakhs) |
1,723.06 |
52 Week High |
1,917.00 |
| 52 Week Low |
1,547.00 |
Price BSE |
1,784.00 |
| Price NSE |
1,782.00 |
Market Capital (₹ Cr.) |
427,933.39 |
| P/C Ratio |
99.20 |
P/E Ratio |
142.60 |
| Price Vs.BV |
19.14 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
4,887.27 |
| NP(₹ Cr.) |
608.70 |
NP Var % |
-70.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
19,974.06 |
| OPM |
29.18 |
NP |
2,757.03 |
| NP Var% |
-29.81 |
EPS |
12.51 |
| PE |
142.57 |
|
|